Document Type : Original Article
Authors
1 Genetic Department, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
2 Genetic Laboratory, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
Abstract
Background & Aims:Thromboembolism is an acute cardiovascular disease that ranges from clinically unimportant to massive embolism. Both acquired and hereditary risk factors contribute to the disease.
We aimed to determine the prevalence of two hereditary predisposing factor of the disease, prothrombin G20210A and factor V Leiden (G1691A) polymorphisms, in Kerman population.
Methods:factor V and factor II genes of 112 healthy individuals were examined to detect factor V Leiden (G1691A) and prothrombin G20210A variants. Genomic DNA of subjects was isolated from leukocytes of the whole blood using salt-saturation method. We used amplification refractory mutation system technique to find G1691A and G20210A variations.
Results: We found two subjects with prothrombin G20210A mutation and three individuals with factor V Leiden variant, both in heterozygote state. The frequency of the polymorphisms were 1.79 and 2.68, respectively. No homozygote or compound heterozygote individual was detected for these two variants in this study.
Conclusion: our findings about the polymorphisms frequency were different from what was detected in other provinces of Iran or in some region of neighboring countries. This discrepancy of the variant frequency can be explained by gene flow phenomenon.
Keywords
- Endler G, Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta 2003; 330(1-2):31–55.
- Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 30-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88(10):3698-703.
- Şahin Ş, Benli I, Aydoğan L. Distribution of prothrombin G20210A, factor V Leiden, and MTHFR C677T mutations in the middle black sea area (Tokat) of Turkey. Turk J Med Sci 2012; 2012; 42 (6): 1093-1097.
- Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001; 86(1):395-403.
- Martinelli I, Battaglioli T, Mannucci PM. Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis. Pharmacogenetics 2003; 13(10):589-94.
- Spannagl M, Heinemann LA, Schramm W. Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism? Eur J Contracept Reprod Health Care 2000; 5(2):105-12.
- Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, et al. Increased efficiency of mRNA 3’ end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 2001; 28(4):389–392.
- Bagheri M, Abdi Rad I. Frequency of the methylenetetrahydrofolate reductase 677CT and 1298AC mutations in an Iranian Turkish female population. Maedica A Journal of Clinical Medicine 2010; 5(3):171-177.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3):1215-16.
- Newton CR, Graham A, Heptinstall LE, Powell SJ, Summeres C, Kalsheker N, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17(7): 2503-16.
- Ranguelov RD, Rosenthal N, Bromley C, Vasef MA. Detection of factor V leiden and prothrombin gene mutations in patients who died with thrombotic events. Arch Pathol Lab Med 2002; 126(10):1193–1196.
- What do we know about heredity and factor V Leiden thrombophilia? http://www.genome.gov/15015167#Q5. Accessed June 16, 2017.
- Rosendaal FR, Reitsma PH. "Genetics of Venous Thrombosis". J Thromb Haemost 2009; 7(1): 301–304.
- Ridker PM, Miletich JP, Hennekens CH, Buring JE. "Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening". JAMA 1997; 277 (16): 1305–7.
- Gregg JP, Yamane AJ, Grody WW. "Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations". American Journal of Medical Genetics 1997; 73 (3): 334–6.
- De Stefano V, Chiusolo P, Paciaroni K, Leone G. "Epidemiology of factor V Leiden: clinical implications". Seminars in Thrombosis and Hemostasis 1998; 24 (4): 367–79.
- Bagheri M, Rad IA. A Multiplex Allele Specific Polymerase Chain Reaction (MAS-PCR) for the Detection of Factor V Leiden and Prothrombin G20210A. Maedica (Buchar) 2011; 6(1):3-9.
- Rahimi Z, Vaisi-Raygani A, Mozafari H, Kharrazi H, Rezaei M, Nagel RL. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran. J Thromb Thrombolysis 2008; 25(3):280-3.
- Karimi M, Panahandeh Shahraki GR, Yavarian M, Afrasiabi A, Dehbozorgian J, et al. Frequency of factor V leiden and prothrombin polymorphism in south of Iran. Iran J Med Sci 2009; 34(2):137-140.
- Fakhr-Eldeen A, Badawy B, Abu A, Fawzy, MS. Factor V Leiden G1691A and Prothrombin G20210A mutations are associated with repeated spontaneous miscarriage in Northern area of Saudi Arabia. Genet.Mol.Res 2017; 16(4):1-8.
- Al-Allawi NA1, Badi AI2, Goran MA3, Nerweyi FF4, Ballo HM5, Al-Mzury NT4. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients. Genet Test Mol Biomarkers 2015; 19(9):500-4.
- Dashti AA, Jordon MM. Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals. Mol Biol Rep 2011; 38(6):3623–3628.
- Nasiruddin, Zahur-ur-Rehman, Anwar M, Ahmed S, Ayyub M, Ali W. Frequency of factor V leiden mutation. J Coll Physicians Surg Pak 2005; 15 (1):15-7.
- Ekim M, Ekim H, Yılmaz YK. The prevalence of Factor V Leiden, prothrombin G20210A, MTHFR C677T and MTHFR A1298C mutations in healthy Turkish population. Hippokratia 2015; 19(4):309-13.
)